Novo’s MFN prices to supersede IRA prices for Ozempic, Wegovy, CMS says
Novo’s MFN prices to supersede IRA prices for Ozempic, Wegovy, CMS says
Novo’s MFN prices to supersede IRA prices for Ozempic, Wegovy, CMS says
A compact weekly email covering company moves, product signals, regulatory updates, and notable funding.